Skip to content

DIADEMA PARTNERS LP

Follow

13F filer, CIK 2026172, MORRISTOWN, NJ

DIADEMA PARTNERS LP reported $383,273,722 across 102 holdings for the quarter ended 2025-03-31, in a 13F-HR filed 2025-05-15. Its ten largest share positions make up 68.21% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001892688-25-000116

Period
2025-03-31
Reported value
$383M
Holdings
102
Top 10 weight
68.21%
New
56
Sold out
61

Largest buys vs the previous quarter

SecurityShares changeApprox. value
REGNnew+29,828$18.9M
LLYnew+19,302$15.9M
JAZZadded+72,470$9M
NBIXnew+62,247$6.88M
ARGXadded+11,600$6.78M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
BMYexited-160,000-$9.05M
ABBVexited-50,000-$8.88M
TEVAexited-300,000-$6.68M
BLUEPRINT MEDICINES CORPexited-64,193-$5.6M
AZNexited-30,000-$3.93M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q1 2025

Share positions as resolved from 13F-HR 0001892688-25-000116, largest first. % of portfolio is the value over $125,147,095, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
REGNREGENERON PHARMACEUTICALSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: 29,828 shares 29,828$18.9M15.12%newTimeline
LLYELI LILLY & COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: 19,302 shares 19,302$15.9M12.74%newTimeline
JAZZJAZZ PHARMACEUTICALS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 14,719 shares; 2025Q1: 87,189 shares 87,189$10.8M8.65%+72,470Timeline
TGTXTG THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 47,805 shares; 2025Q1: 207,883 shares 207,883$8.2M6.55%+160,078Timeline
ARGXARGENX SEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 679 shares; 2025Q1: 12,279 shares 12,279$7.18M5.74%+11,600Timeline
NBIXNEUROCRINE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: 62,247 shares 62,247$6.88M5.5%newTimeline
SLNOSOLENO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 71,988 shares; 2025Q1: 93,002 shares 93,002$6.64M5.31%+21,014Timeline
BMRNBIOMARIN PHARMACEUTICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: 52,877 shares 52,877$3.74M2.99%newTimeline
ALNYALNYLAM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: 13,115 shares 13,115$3.54M2.83%newTimeline
PCVXVAXCYTE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 10,000 shares; 2025Q1: 92,385 shares 92,385$3.49M2.79%+82,385Timeline
IMCRIMMUNOCORE HLDGS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: 96,984 shares 96,984$2.88M2.3%newTimeline
RYTMRHYTHM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 75,000 shares; 2025Q1: 50,000 shares 50,000$2.65M2.12%-25,000Timeline
SPRINGWORKS THERAPEUTICS INCSPRINGWORKS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: 60,000 shares 60,000$2.65M2.12%new
VKTXVIKING THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: 104,121 shares 104,121$2.51M2.01%newTimeline
CNTACENTESSA PHARMACEUTICALS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 131,862 shares; 2025Q1: 164,048 shares 164,048$2.36M1.88%+32,186Timeline
COGTCOGENT BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 90,000 shares; 2025Q1: 392,213 shares 392,213$2.35M1.88%+302,213Timeline
VRDNVIRIDIAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 49,478 shares; 2025Q1: 162,063 shares 162,063$2.18M1.75%+112,585Timeline
SRRKSCHOLAR ROCK HLDG CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 53,160 shares; 2025Q1: 57,923 shares 57,923$1.86M1.49%+4,763Timeline
89BIO INC89BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: 231,436 shares 231,436$1.68M1.34%new
NVONOVO-NORDISK A SQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: 24,618 shares 24,618$1.68M1.34%newTimeline
KALVKALVISTA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: 135,509 shares 135,509$1.56M1.25%newTimeline
APGEAPOGEE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 50,620 shares; 2025Q1: 40,000 shares 40,000$1.49M1.19%-10,620Timeline
SAGE THERAPEUTICS INCSAGE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: 183,466 shares 183,466$1.46M1.17%new
VTGNVISTAGEN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 442,520 shares; 2025Q1: 565,975 shares 565,975$1.41M1.13%+123,455Timeline
ASNDASCENDIS PHARMA A/SQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 25,276 shares; 2025Q1: 8,321 shares 8,321$1.3M1.04%-16,955Timeline
TRVITREVI THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: 180,000 shares 180,000$1.13M0.9%newTimeline
RLAYRELAY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 505,778 shares; 2025Q1: 426,346 shares 426,346$1.12M0.89%-79,432Timeline
PCRXPACIRA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: 38,926 shares 38,926$967K0.77%newTimeline
URGNUROGEN PHARMA LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 50,000 shares; 2025Q1: 76,220 shares 76,220$843K0.67%+26,220Timeline
CLYMCLIMB BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 374,423 shares; 2025Q1: 669,803 shares 669,803$817K0.65%+295,380Timeline
CYTKCYTOKINETICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: 20,000 shares 20,000$804K0.64%newTimeline
REPLREPLIMUNE GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 114,000 shares; 2025Q1: 74,530 shares 74,530$727K0.58%-39,470Timeline
Reviva Pharmaceuticals Hold…Reviva Pharmaceuticals Holdings I…Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: 650,723 shares 650,723$621K0.5%new
ALECALECTOR INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 239,019 shares; 2025Q1: 456,546 shares 456,546$562K0.45%+217,527Timeline
QUREUNIQURE NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: 36,500 shares 36,500$387K0.31%newTimeline
OLMAOLEMA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: 100,000 shares 100,000$376K0.3%newTimeline
GOSSGOSSAMER BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 217,987 shares; 2025Q1: 269,589 shares 269,589$297K0.24%+51,602Timeline
PRQRPROQR THRAPEUTICS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 158,023 shares; 2025Q1: 207,694 shares 207,694$276K0.22%+49,671Timeline
ELDNELEDON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 75,794 shares; 2025Q1: 64,613 shares 64,613$219K0.18%-11,181Timeline
MREOMEREO BIOPHARMA GROUP PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: 492,215 shares 492,215$169K0.13%newTimeline
TERNTERNS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 50,370 shares; 2025Q1: 56,098 shares 56,098$155K0.12%+5,728Timeline
SGMTSAGIMET BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: 46,019 shares 46,019$150K0.12%newTimeline
CADLCANDEL THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 20,000 shares; 2025Q1: 25,045 shares 25,045$142K0.11%+5,045Timeline

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
AMGNAMGEN INC COMcall103,300$32.2Mnew
PFEPFIZER INC COMcall900,000$22.8Mnew
CORTCORCEPT THERAPEUTICS INC COMput150,200$17.2Mnew
LLYELI LILLY & CO COMput20,700$17.1Mnew
AMGNAMGEN INC COMput52,100$16.2Mnew
SLNOSOLENO THERAPEUTICS INC COMcall219,400$15.7M+124,800
SLNOSOLENO THERAPEUTICS INC COMput217,000$15.5M+41,600
REGNREGENERON PHARMACEUTICALS Stockput20,000$12.7Mnew
JAZZJAZZ PHARMACEUTICALS PLC Stockcall70,800$8.79Mnew
NVONOVO-NORDISK A S ADRput124,600$8.65Mnew
LLYELI LILLY & CO COMcall10,000$8.26Mnew
NVONOVO-NORDISK A S ADRcall108,700$7.55Mnew
ALNYALNYLAM PHARMACEUTICALS INC Stockput20,000$5.4Mnew
APGEAPOGEE THERAPEUTICS INC Stockcall126,300$4.72Mnew
CORTCORCEPT THERAPEUTICS INC COMcall40,000$4.57Mnew
BBIOBRIDGEBIO PHARMA INC COMcall131,400$4.54M+31,400
RAREULTRAGENYX PHARMACEUTICAL IN COMput123,300$4.46M+17,800
RAREULTRAGENYX PHARMACEUTICAL IN COMcall117,000$4.24M+64,700
CRSPCRISPR THERAPEUTICS AG Stockcall112,000$3.81M-78,800
RXRXRECURSION PHARMACEUTICALS IN CL Acall698,400$3.69M+398,400
AGIOAGIOS PHARMACEUTICALS INC COMcall119,700$3.51M+17,700
MRNAMODERNA INC COMput100,000$2.83Mnew
MNKDMANNKIND CORP Stockcall519,900$2.62Mnew
ANABANAPTYSBIO INC COMput117,300$2.18M+17,300
EWTXEDGEWISE THERAPEUTICS INC COMcall98,200$2.16Mnew
ZYMEZYMEWORKS INC COMcall179,300$2.14Mnew
ALTALTIMMUNE INC COM NEWcall418,800$2.09M+218,800
PCVXVAXCYTE INC Stockput51,600$1.95Mnew
ANABANAPTYSBIO INC COMcall96,800$1.8M-118,200
QUREUNIQURE NV SHScall154,100$1.63M+54,100
KROSKEROS THERAPEUTICS INC Stockcall147,100$1.5M+17,100
MRNAMODERNA INC COMcall52,100$1.48Mnew
VKTXVIKING THERAPEUTICS INC COMcall50,000$1.21Mnew
COGTCOGENT BIOSCIENCES INC COMput201,400$1.21Mnew
KALVKALVISTA PHARMACEUTICALS INC COMcall103,300$1.19Mnew
MREOMEREO BIOPHARMA GROUP PLC CMNcall515,200$1.16Mnew
FOLDAMICUS THERAPEUTIC COMcall131,400$1.07M+31,400
OCULOCULAR THERAPEUTIX INC COMcall136,700$1M+32,700
GOSSGOSSAMER BIO INC Stockcall824,800$907K+567,900
KROSKEROS THERAPEUTICS INC Stockput65,800$671K+15,400
CRDFCARDIFF ONCOLOGY INC COMcall208,100$653Knew
EOLSEVOLUS INC COMput50,000$602Knew
VERVE THERAPEUTICS INCVERVE THERAPEUTICS INC COMcall116,900$534Knew
SMMTSUMMIT THERAPEUTICS INC COMcall24,700$476K+4,700
NEKTAR THERAPEUTICSNEKTAR THERAPEUTICS COMcall678,200$461Knew
FLNAFILANA THERAPEUTICS INC CMNcall300,000$450Knew
CMPXCOMPASS THERAPEUTICS INC COMcall200,000$380Knew
BMEABIOMEA FUSION INC CMNput170,100$362K+98,700
UNITY BIOTECHNOLOGY INC COM…UNITY BIOTECHNOLOGY INC COM NEW Stockcall346,900$361Knew
IMUXIMMUNIC INC COMcall317,800$346Knew
RLAYRELAY THERAPEUTICS INC Stockcall131,400$344K+31,400
CAPRCAPRICOR THERAPEUTICS INC COMMON STOCKcall30,300$288K-169,700
UNITY BIOTECHNOLOGY INC COM…UNITY BIOTECHNOLOGY INC COM NEW Stockput215,200$224Knew
ATYRATYR PHARMA INC COM NEWcall54,700$165Knew
MREOMEREO BIOPHARMA GROUP PLC CMNput39,400$88.7Knew
ATYRATYR PHARMA INC COM NEWput11,800$35.6Knew
FLNAFILANA THERAPEUTICS INC CMNput9,900$14.8K-361,400
JAZZJAZZ PHARMACEUTICALS PLC Stockput100$12.4Knew
VTGNVISTAGEN THERAPEUTICS INC COMcall200$5000

Sold out in Q1 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
VRTXVERTEX PHARMACEUTICALS INC57,400$23.1Mcall
XBISPDR SERIES TRUST200,000$18Mput
BMYBRISTOL-MYERS SQUIBB CO160,000$9.05Mshares
ABBVABBVIE INC50,000$8.88Mshares
ABBVABBVIE INC50,000$8.88Mput
ACLXARCELLX INC100,000$7.67Mput
TEVATEVA PHARMACEUTICAL INDS LTD300,000$6.68Mshares
TGTXTG THERAPEUTICS INC200,000$6.02Mput
BLUEPRINT MEDICINES CORPBLUEPRINT MEDICINES CORP64,193$5.6Mshares
HALOHALOZYME THERAPEUTICS INC100,000$4.78Mcall
AZNASTRAZENECA PLC-SPONS ADR30,000$3.93Mshares
INSMINSMED INC56,337$3.89Mshares
BHVNBIOHAVEN LTD100,000$3.73Mcall
INTRA-CELLULAR THERAPIES INCINTRA-CELLULAR THERAPIES INC43,700$3.65Mcall
INSMINSMED INC50,000$3.45Mcall
TARSTARSUS PHARMACEUTICALS INC60,000$3.32Mshares
APLSAPELLIS PHARMACEUTICALS INC100,000$3.19Mcall
CLDXCELLDEX THERAPEUTICS INC NEW100,000$2.53Mcall
RCUSARCUS BIOSCIENCES INC165,965$2.47Mshares
SRRKSCHOLAR ROCK HLDG CORP43,000$1.86Mcall
ORICORIC PHARMACEUTICALS INC214,291$1.73Mshares
CRNXCRINETICS PHARMACEUTICALS IN25,900$1.32Mshares
DNLIDENALI THERAPEUTICS INC60,000$1.22Mshares
NUVLNUVALENT INC14,701$1.15Mshares
EOLSEVOLUS INC97,423$1.08Mshares
KROSKEROS THERAPEUTICS INC63,547$1.01Mshares
BNTXBIONTECH SE8,767$999Kshares
JANXJANUX THERAPEUTICS INC17,500$937Kput
NMRANEUMORA THERAPEUTICS INC.81,200$861Kcall
CAPRCAPRICOR THERAPEUTICS INC58,700$810Kput
ACLXARCELLX INC10,100$775Kshares
IOVAIOVANCE BIOTHERAPEUTICS INC100,000$740Kcall
VIRVIR BIOTECHNOLOGY INC100,000$734Kcall
GHRSGH RESEARCH PLC101,502$711Kshares
GERNGERON CORP200,000$708Kshares
NEKTAR THERAPEUTICSNEKTAR THERAPEUTICS698,919$650Kshares
AEROVATE THERAPEUTICS INCAEROVATE THERAPEUTICS INC191,600$508Kput
ONCBEONE MEDICINES LTD30,000$422Kshares
ERASERASCA INC156,973$394Kshares
ZVRAZEVRA THERAPEUTICS INC42,081$351Kshares
ALXOALX ONCOLOGY HLDGS INC197,680$330Kshares
WAVEECO WAVE POWER GLOBAL AB23,600$292Kcall
CCCCC4 THERAPEUTICS INC80,100$288Kcall
CADLCANDEL THERAPEUTICS INC32,900$286Kput
SMMTSUMMIT THERAPEUTICS INC8,500$152Kput
QTTBQ32 BIO INC35,100$121Kput
SABSSAB BIOTHERAPEUTICS INC30,000$114Kshares
CHIMERIX INC COMCHIMERIX INC COM29,082$101Kshares
KODKODIAK SCIENCES INC7,300$72.6Kcall
QTTBQ32 BIO INC19,700$67.8Kshares
LRMRLARIMAR THERAPEUTICS INC16,900$65.4Kput
ALXOALX ONCOLOGY HLDGS INC38,900$65Kcall
ARVNARVINAS INC2,300$44.1Kput
EWTXEDGEWISE THERAPEUTICS INC1,359$36.3Kshares
SPRYARS PHARMACEUTICALS INC3,200$33.8Kcall
MIND MEDICINE MINDMED INCMIND MEDICINE MINDMED INC4,710$32.8Kshares
LAVA THERAPEUTICS NVLAVA THERAPEUTICS NV21,508$20.5Kshares
QTTBQ32 BIO INC5,600$19.3Kcall
Aptevo Therapeutics Inc (US…Aptevo Therapeutics Inc (US) OLD4,050$17.5Kshares
LRMRLARIMAR THERAPEUTICS INC3,800$14.7Kshares
LXRXLEXICON PHARMACEUTICALS INC800$591call

How Q1 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001892688-25-000116 base2025-05-15acceptance time not in the bulk data set